Back
Intellia Therapeutics, Inc. Stock Predictions
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
16
NTLA
Intellia Therapeutics, Inc.
Last Price:
$9.75
Seasonality Move:
-7.2%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiIntellia Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Intellia Therapeutics, Inc. has on average historically risen by 14% based on the past 9 years of stock performance.
-
Intellia Therapeutics, Inc. has risen higher in 3 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
-
Is Intellia Therapeutics, Inc. Stock Undervalued?The current Intellia Therapeutics, Inc. [NTLA] share price is $9.06. The Score for NTLA is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
-
NTLA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Intellia Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Intellia Therapeutics, Inc. has on average historically risen by 14% based on the past 9 years of stock performance.
Intellia Therapeutics, Inc. Stock Rating
Sell
16
Intellia Therapeutics, Inc. (NTLA)
is a Sell
Is Intellia Therapeutics, Inc. overpriced?
-
Intellia Therapeutics, Inc. has risen higher in 3 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
Intellia Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
intelliatx.com
52-Week Data
52-Week High:
28.25
52-Week Low:
5.90
Prediction Charts
Market Cap:
1B
Price in USD:
9.06
Volume:
4.7M
Beta:
2.10
Technical Analysis
SMA50:
15.79
SMA100:
13.92
SMA200:
11.42
52-Wk Change:
-38.16%
Stock Predictions
-
Is Intellia Therapeutics, Inc. stock public?Yes, Intellia Therapeutics, Inc. is a publicly traded company.
-
What is the Intellia Therapeutics, Inc. stock quote today?The Intellia Therapeutics, Inc. stock price is 9.06 USD today.
-
How to buy Intellia Therapeutics, Inc. stock online?You can buy Intellia Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 8.49 | 8.70 | 8.88 | 8.38 |
| Nov-17 | 8.56 | 8.48 | 8.81 | 8.23 |
| Nov-18 | 8.45 | 8.47 | 8.63 | 8.22 |
| Nov-19 | 8.53 | 8.24 | 8.63 | 8.20 |
| Nov-20 | 8.50 | 8.04 | 8.88 | 7.95 |
| Nov-21 | 8.15 | 8.21 | 8.43 | 7.95 |
| Nov-24 | 8.26 | 8.35 | 8.37 | 8.14 |
| Nov-25 | 8.39 | 8.55 | 8.61 | 8.18 |
| Nov-26 | 8.63 | 8.52 | 8.63 | 8.40 |
| Nov-28 | 8.62 | 8.99 | 9.10 | 8.53 |
| Dec-1 | 8.81 | 8.42 | 8.89 | 8.40 |
| Dec-2 | 8.43 | 8.10 | 8.49 | 8.09 |
| Dec-3 | 8.23 | 9.06 | 9.12 | 8.13 |
| Dec-4 | 8.91 | 9.74 | 9.92 | 8.85 |
Intellia Therapeutics, Inc. Earnings
Intellia Therapeutics, Inc. Earnings Report: Per Share Intellia Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Intellia Therapeutics, Inc. Forecast Revenue Growth
Intellia Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Intellia Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.31 per share, and an increase next year of $0.36 per share.
* Intellia Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.